First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study.
Naganuma M, Shiga H, Shimoda M, Matsuura M, Takenaka K, Fujii T, Yamamoto S, Matsubayashi M, Kobayashi T, Aoyama N, Saito D, Yokoyama K, Moriya K, Tsuchiya K, Shibui S, Kawamoto A, Shimizu H, Okamoto R, Sakamoto K, Yaguchi K, Kunisaki R, Akiyama S, Hayashi R, Hasui K, Kanmura S, Bamba S, Mishima Y, Kakimoto K, Sugimoto S, Nakazawa A, Abe T, Ogata H, Hisamatsu T; Collaborators of the Study.
Naganuma M, et al. Among authors: yamamoto s.
J Gastroenterol. 2025 Jan 30. doi: 10.1007/s00535-025-02216-0. Online ahead of print.
J Gastroenterol. 2025.
PMID: 39883201